The largest database of trusted experimental protocols

E coli bl21 strain

Manufactured by GE Healthcare
Sourced in United Kingdom

E. coli BL21 strain is a bacterial expression host commonly used in molecular biology and protein production. It is a well-characterized strain that is widely utilized for the expression of recombinant proteins. The BL21 strain is derived from the parental E. coli B strain and is designed to enhance protein expression and solubility.

Automatically generated - may contain errors

3 protocols using e coli bl21 strain

1

Recombinant Protein Expression in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cloned nucleotide sequences were expressed as glutathione S-transferase (GST) fusion proteins in the E. coli BL21 strain according to the manufacturer’s instructions (GE Healthcare Life Sciences, UK). The expression was done at 37°C for 4 hours after induction with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The resulting E. coli cells were washed three times with phosphate-buffered saline (PBS) pH 7.4, lysed with 1% Triton in PBS, sonicated and then centrifuged at 10,000 rpm for 30 min at 4°C. Supernatant was purified with Glutathione-Sepharose 4B beads according to the manufacturer’s instructions (GE Healthcare Life Sciences, UK). The protein concentration was measured by using a Pierce BCA Protein Assay Kit (Thermo Scientific, USA).
+ Open protocol
+ Expand
2

Bacterial Strain Utilization for Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Escherichia coli DH5α strain was purchased from TOYOBO, Japan. E. coli BL21 strain was used to express the GST fusion protein and was purchased from GE Healthcare, Japan [11 (link)].
+ Open protocol
+ Expand
3

Recombinant Protein Production in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pCold-NPGM-Gly plasmid was transformed into E. coli BL21 strain (GE Healthcare, Little Chalfont, UK) or E. coli SHuffle strain (New England Biolabs, Ipswich, MA, USA). The transformants were selected on LB agar plates containing 50 μg/ml of ampicillin and grown at 37 °C overnight. The colonies were then grown in LB medium containing ampicillin at 37 °C overnight. An aliquot of the pre-culture solution was diluted with 200 ml of fresh LB medium and incubated at 37 °C. When the cells reached an optical density (OD)600 of 0.5, the culture was refrigerated at 15 °C for 30 min. The culture solution was added with isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final concentration of 0.1 mM and continued with shaking at 15 °C for 24 h. Cells were collected by centrifugation and frozen at −80 °C until further use.
The expression of the target protein in soluble and in insoluble fractions was confirmed by SDS–PAGE. An aliquot of the cell pellet was lysed with BugBuster Protein Extraction Reagent (Novagen, Madison, WI, USA) and separated by centrifugation. Each sample was dissolved in SDS sample buffer and subjected to 15% SDS–PAGE. The gels were stained with 2D-SILVER STAIN II (Cosmobio, Tokyo, Japan).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!